Square planar
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
The square planar molecular geometry in chemistry describes the stereochemistry (spatial arrangement of atoms) that is adopted by certain chemical compounds. As the name suggests, molecules of this geometry have their atoms lying in a square about a central atom.
Relatively few compounds adopt this geometry, but these species are often notable and even useful, examples being the first noble gas compound XeF4 and the anticancer drug Cisplatin (PtCl2(NH3)2).
This geometry can be visualised as resulting from the removal of a pair of ligands from the z-axis of an octahedron, leaving four ligands in the x-y plane. For transition metal compounds, the orbital splitting diagram for square planar geometry can thus be derived from the octahedral diagram. The removal of the two ligands stabilizes the dz2 level, leaving the dx2-y2 level as the most destabilized. Consequenly the dx2-y2 remains unoccupied in complexes of metals with the d8 configuration. These compounds typically have 16 valence electrons (eight from ligands, eight from the metal). Examples include Vaska's complex, Zeise's salt and Crabtree's catalyst.[1]
See also
- For the other possible molecular geometries: AXE method.
References
- ↑ G. L. Miessler and D. A. Tarr “Inorganic Chemistry” 3rd Ed, Pearson/Prentice Hall publisher, ISBN 0-13-035471-6.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

